Infectious Vaginitis, Cervicitis, and Pelvic Inflammatory Disease.
Shroff S.
Med Clin North Am. 2023 Mar;107(2):299-315. doi: 10.1016/j.mcna.2022.10.009. Epub 2022 Dec 26.
Guideline: Vulvovaginal candidosis (AWMF 015/072, level S2k).
Farr A, Effendy I, Frey Tirri B, Hof H, Mayser P, Petricevic L, Ruhnke M, Schaller M, Schaefer APA, Sustr V, Willinger B, Mendling W.
Mycoses. 2021 Jun;64(6):583-602. doi: 10.1111/myc.13248. Epub 2021 Feb 27.
Menopause and Sexuality.
Thornton K, Chervenak J, Neal-Perry G.
Endocrinol Metab Clin North Am. 2015 Sep;44(3):649-61. doi: 10.1016/j.ecl.2015.05.009.
Lasers in Gynecology.
Iglesia CB, Choi JE, Tadir Y.
Obstet Gynecol. 2024 Aug 1;144(2):181-194. doi: 10.1097/AOG.0000000000005635. Epub 2024 Jun 6.
Chronic recurrent vulvovaginitis is not only due to Candida.
Arechavala A, Negroni R, Santiso G, Depardo R, Bonvehí P.
Rev Iberoam Micol. 2021 Jul-Sep;38(3):132-137. doi: 10.1016/j.riam.2021.03.002. Epub 2021 Jun 4.
Urinary retention in adults: diagnosis and initial management.
Selius BA, Subedi R.
Am Fam Physician. 2008 Mar 1;77(5):643-50.
Hormone therapy regimens for managing the menopause and premature ovarian insufficiency.
Armeni E, Paschou SA, Goulis DG, Lambrinoudaki I.
Best Pract Res Clin Endocrinol Metab. 2021 Dec;35(6):101561. doi: 10.1016/j.beem.2021.101561. Epub 2021 Jun 30.
Boric acid for recurrent vulvovaginal candidiasis: the clinical evidence.
Iavazzo C, Gkegkes ID, Zarkada IM, Falagas ME.
J Womens Health (Larchmt). 2011 Aug;20(8):1245-55. doi: 10.1089/jwh.2010.2708. Epub 2011 Jul 20.
New Innovations for the Treatment of Vulvovaginal Atrophy: An Up-to-Date Review.
Benini V, Ruffolo AF, Casiraghi A, Degliuomini RS, Frigerio M, Braga A, Serati M, Torella M, Candiani M, Salvatore S.
Medicina (Kaunas). 2022 Jun 6;58(6):770. doi: 10.3390/medicina58060770.
Chronic vulvovaginal candidiasis.
Nyirjesy P.
Am Fam Physician. 2001 Feb 15;63(4):697-702.
